PCRX Earnings

Quarterly EPS
$-3.11
Q3 2024
$0.35
Q4 2024
$0.10
Q1 2025
$-0.11
Q2 2025
$0.12
Q3 2025
$0.04
Q4 2025
$0.07
Q1 2026
$0.12
Q2 2026
Latest Revenue192.4M
Latest Net Income4.7M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.12192.4M4.7M+6.2%+209.1%
Q1 2026$0.07177.4M2.9M+5.0%-30.0%
Q4 2025$0.04196.9M1.6M+5.1%-88.6%
Q3 2025$0.12179.5M5.4M+6.5%+103.9%
Q2 2025-$0.11181.1M-4847000+1.7%-126.8%
Q1 2025$0.10168.9M4.8M+1.1%-47.4%
Q4 2024$0.35187.3M16.0M+3.3%-35.2%
Q3 2024-$3.11168.6M-143466000+2.8%-1,452.2%
Q2 2024$0.41178.0M18.9M
Q1 2024$0.19167.1M9.0M
Q4 2023$0.54181.2M24.9M
Q3 2023$0.23163.9M10.9M
Pacira BioSciences (PCRX) — Earnings